Clinical Trial Update: Abatacept for the Treatment of Myositis-associated Interstitial Lung Disease [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating abatacept for myositis-associated interstitial lung disease has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease
• Myositis

Drugs mentioned

• Abatacept (abatacept)

Snippet

Sponsor: Rohit Aggarwal, MD | Conditions: Myositis, Interstitial Lung Disease | Phase 2 | Status: COMPLETED | Results posted: 2025-01-07